Page last updated: 2024-08-02 07:14:59

sri 224

Description

Cross-References

ID SourceID
PubMed CID9561005
CHEMBL ID223505
MeSH IDM0453807

Synonyms (14)

Synonym
[(e)-1-(4-methoxyphenyl)ethylideneamino]thiourea
sri-224
AKOS000506378
CHEMBL223505 ,
p-methoxyphenyl(methyl)thiosemicarbazone
bdbm50302754
9P-047
[(e)-[1-(4-methoxyphenyl)ethylidene]amino]thiourea
150059-53-3
2-[(e)-1-(4-methoxyphenyl)ethylidene]-1-hydrazinecarbothioamide
sr-01000310617
SR-01000310617-1
(1e)-1-(4-methoxyphenyl)ethanone thiosemicarbazone
mfcd00808617

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC500.1100AID444073

Bioassays (12)

Assay IDTitleYearJournalArticle
AID178190Effective dose for protection against seizures induced in the maximal electroshock anticonvulsant screen test 1 hr after oral dosing in rat1993Journal of medicinal chemistry, Aug-06, Volume: 36, Issue:16
ISSN: 0022-2623
Anticonvulsant activities of some arylsemicarbazones displaying potent oral activity in the maximal electroshock screen in rats accompanied by high protection indices.
AID190125Neurotoxicity was determined, 1 hr after oral dosing in rat.1993Journal of medicinal chemistry, Aug-06, Volume: 36, Issue:16
ISSN: 0022-2623
Anticonvulsant activities of some arylsemicarbazones displaying potent oral activity in the maximal electroshock screen in rats accompanied by high protection indices.
AID598528Inhibition of alpha-MSH-induced melanin production in mouse B16 cells at 10 uM after 3 days2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
ISSN: 1464-3405
Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition.
AID283663Antimycobacterial activity against Mycobacterium bovis BCG NCTC 56922007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
ISSN: 0066-4804
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID598529Inhibition of alpha-MSH-induced melanin production in mouse B16 cells after 3 days2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
ISSN: 1464-3405
Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition.
AID283671Antimycobacterial activity against Mycobacterium bovis BCG str. Pasteur 1173P2 overexpressing ethA gene2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
ISSN: 0066-4804
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID444073Inhibition of mushroom tyrosinase2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
ISSN: 1464-3405
Discovery of 4-functionalized phenyl-O-beta-D-glycosides as a new class of mushroom tyrosinase inhibitors.
AID283664Antimycobacterial activity against Mycobacterium bovis BCG NCTC 5692 with ethR-knockout mutant2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
ISSN: 0066-4804
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID1659814Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as reduction in mycolic acids synthesis after 8 hrs in presence of [1, 2-14C]-acetate by TLC analysis2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
ISSN: 1520-4804
Molecule Property Analyses of Active Compounds for
AID283670Antimycobacterial activity against Mycobacterium bovis BCG str. Pasteur 1173P2 overexpressing ethR gene2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
ISSN: 0066-4804
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID283662Antimycobacterial activity against Mycobacterium tuberculosis H37Rv2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
ISSN: 0066-4804
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.
AID283669Antimycobacterial activity against Mycobacterium bovis BCG Pasteur with pMV261 vector2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
ISSN: 0066-4804
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets.

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
clofaziminemonochlorobenzenes;
phenazines
dye;
leprostatic drug;
non-steroidal anti-inflammatory drug
202020204.0low000010
kojic acid4-pyranones;
enol;
primary alcohol
Aspergillus metabolite;
EC 1.10.3.1 (catechol oxidase) inhibitor;
EC 1.10.3.2 (laccase) inhibitor;
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 1.4.3.3 (D-amino-acid oxidase) inhibitor;
NF-kappaB inhibitor;
skin lightening agent
2011201113.0low000010
tropolonealpha-hydroxy ketone;
cyclic ketone;
enol
bacterial metabolite;
fungicide;
toxin
2009200915.0low000100
4(5)-phenylimidazole202020204.0low000010
arbutinbeta-D-glucoside;
monosaccharide derivative
Escherichia coli metabolite;
plant metabolite
2009201114.0low000110
linezolidacetamides;
morpholines;
organofluorine compound;
oxazolidinone
antibacterial drug;
protein synthesis inhibitor
202020204.0low000010
pa 824202020204.0low000010
bm 212202020204.0low000010
u 100480202020204.0low000010
ethionamidepyridines;
thiocarboxamide
antilipemic drug;
antitubercular agent;
fatty acid synthesis inhibitor;
leprostatic drug;
prodrug
2007200717.0low000100
thiocarlidethioureas2007200717.0low000100
sq 109202020204.0low000010
bedaquilinearomatic ether;
naphthalenes;
organobromine compound;
quinolines;
tertiary alcohol;
tertiary amino compound
antitubercular agent;
ATP synthase inhibitor
202020204.0low000010
sri 2862007202010.5high000110
opc-67683piperidines202020204.0low000010
helicide2009200915.0high000100
thioacetazone2007202010.5low000110
helicideglycoside2009200915.0low000100
btz 043202020204.0low000010
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Absence Seizure01993199331.0medium001000
B16 Melanoma02011201113.0medium000010
Koch's Disease0202020204.0medium000010
Seizures01993199331.0medium001000
Tuberculosis0202020204.0medium000010